Obstetrics News
-
Onconova Therapeutics Announces Plans For A Phase 1/2a Trial Of Narazaciclib Combined With Letrozole In Endometrial Cancer, Reports Third Quarter 2022 Financial Results, And Provides A Business Update
Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced plans for a Phase 1/2a trial of narazaciclib combined with letrozole in recurrent metastatic low-grade endometrioid endometrial cancer (LGEEC). In addition, the Company reported its third ...
-
Mirena approved in Europe for extended duration of use in contraception
Mirena (52mg LNG IUS), Bayer’s long-acting reversible intrauterine system, received regulatory approval in the European Workshare Procedure for up to eight years in contraception, now offering the longest contraceptive duration of use for any hormonal intrauterine system – national approvals expected in Q4 The IUS is one of the most effective birth control methods Mirena was also ...
By Bayer AG
-
Daily Inspiration: Meet Gillian Henker
Today we’d like to introduce you to Gillian Henker. Hi Gillian, we’re thrilled to have a chance to learn your story today. So, before we get into specifics, maybe you can briefly walk us through how you got to where you are today. In 2014, Gillian Henker co-founded Sisu Global, leading the company’s products and technical strategy. Henker is the primary inventor of Hemafuse ...
-
Know your Pain Management Options During Labor
Expecting a baby is undoubtedly a life changing event, and there are many factors to consider along the way. The crescendo of the nine month journey is of course the act of giving birth itself, but a chief concern among expecting mothers is “how will I manage my labor pain?” There will definitely be some discomfort involved, but it can be difficult to anticipate how much. Mothers ...
-
Aresus announces presentation of clincial data for the treatment of female sexual pain with sinecatechins ointment
Aresus Pharma GmbH, a subsidiary of DERMAGO GmbH, announced today that clinical results on the efficacy of 5-10% Topical Sinecatechins (synonyms: “Polyphenon® E“, ”defined extract from green tea leaves“) Ointment for Postmenopausal Vestibulodynia1 were presented at the 2nd Congress on Women’s Health Innovations & Inventions in Tel Aviv on July 11-12th, 2022. ...
-
Role of oxygen generator in the epidemic period of coronavirus disease
Why is the oxygen generator important? Oxygen is a life-saving therapeutic gas, which is often used to treat patients with severe pneumonia and other respiratory diseases. Oxygen generator is an electric medical equipment. It first inhales air, removes nitrogen, then generates a continuous oxygen source, and delivers concentrated oxygen to patients who need respiratory support in a controlled ...
-
Medical Microinstruments Launches New Simulator for Robotic Microsurgery
PISA, Italy, May 26,2022 - Medical Microinstruments (MMI) SpA. a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced the launch of its Symani Surgical System Simulator developed by VirtaMed. The simulator will improve, expand, and digitize the pathways for Symani training as surgeons prepare to expand their microsurgical skills through ...
-
Santa Barbara Cottage Hospital Enhances Maternal and Fetal Safety with Go-Live of PeriGen’s PeriWatch Vigilance
PeriGen®, an innovator in perinatal early warning systems, today announced that Santa Barbara Cottage Hospital, a 519-bed acute care teaching hospital and trauma center that is part of the not-for-profit Cottage Health system, is now using PeriGen’s PeriWatch Vigilance® automated maternal-fetal early warning system (EWS) in its labor and delivery (L&D) department. Founded in ...
-
Proximie Partners with Jhpiego in New Initiative to Improve Obstetric Surgical Care
Proximie has teamed up with Jhpiego, a Johns Hopkins University affiliate, on a safe surgery project in Kenya to layer in their unique software that allows physicians anywhere in the world to virtually "scrub-in" and mentor colleagues in real time. Proximie has offered its technology to Jhpiego, a global health non-profit working in 40-plus countries, to improve obstetric surgical care for ...
-
KitoTech Medical Announces Series B Round Financing
KitoTech Medical, a Seattle-based medical device company, announced today that it has completed the first close of approximately $2M of its Series B Round where there is the potential to raise a total of $6M. The proceeds from the financing will be primarily used to increase KitoTech’s commercial efforts in the medical market to increase the use of and drive sales of its microMend® ...
-
News Find here our latest news and events to come Search an article Robocath successfully performs first carotid stenting in France with R-One robot at Rennes University Hospital 24 November 2021 Rouen, France, November 24, 2021 - Robocath, a company
Robocath, a company that designs, develops and commercializes robotic solutions to treat cardiovascular diseases, and Rennes University Hospital, today announce the launch of a co-development research program using robotics to improve treatment for stroke victims. With the support of Philips France, this unique program will be implemented over the next four years. It will focus on the use of ...
By Robocath
-
Guided Therapeutics Announces Start of Chinese Clinical Trial for Approval to Market and Sell LuViva in China
Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, based on its patented biophotonic technology, announced today that enrollment and testing of patients has begun at the Department of Obstetrics & Gynecology Hospital of Fudan University located in Shanghai. The data will be submitted to the Chinese National Medical Products Administration (NMPA; formerly ...
-
Agplus Appoints New Chief Scientific Officer
Ahead of their attendance at this year’s MEDICA event, AgPlus have appointed a new Chief Scientific Officer, Dr Nic Christofides, who has vast experience of finalising late stage clinical assays to ensure commercial success. Of Cypriot descent, Dr Christofides started his career in 1973 at Hammersmith Hospital, London, as a research assistant where he developed immunoassay for Oestriol ...
-
Memic Innovative Surgery to Demonstrate Use of Hominis® Surgical System at AAGL 2021
Company to showcase first and only FDA-authorized surgical robot that features miniature humanoid-shaped arms and host in-booth surgeons to discuss their experiences with Hominis Tel Aviv, Israel and Fort Lauderdale, FL, November 11, 2021 – Memic Innovative Surgery (Memic), a medical device company dedicated to transforming healthcare with its proprietary surgical robotic technology, ...
-
PeriGen Deploys Mobile Version of PeriWatch Vigilance to Further Protect Moms and Babies During Childbirth
PeriGen Inc., the market leader in applying artificial intelligence (AI) to improve safety in childbirth, today introduced PeriWatch Vigilance® Mobile, a full-function browser-based solution providing access to its early warning system (EWS) and clinical decision support tool. By providing remote access to the full range of conditions monitored by PeriWatch Vigilance, the new solution ...
-
SCL Health to Deploy System-Wide OB Hub Powered by PeriWatch Command Center
PeriGen Inc., the market leader in applying artificial intelligence (AI) to improve safety in childbirth, today announced that SCL Health, a health system operating eight hospitals and 150 clinics in Colorado and Montana, is launching a centralized SCL Health OB Hub utilizing PeriGen’s PeriWatch Command Center enterprise-wide telehealth-platform. Through the OB Hub, a dedicated team of ...
-
Guided Therapeutics Ships LuViva Devices to China for Start of Clinical Trial; Receives Additional $100,000 Payment
Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, based on its patented biophotonic technology, announced today that its Chinese partner, Shandong Yaohua Medical Instrument Corporation (SMI), had received ethics board approval and placed LuViva devices at two of the three participating hospitals for clinical trials aimed at achieving Chinese FDA approval. ...
-
Gynesonics Announces First Office-Based Sonata Procedure in the State of Texas
Redwood City, CA, October 5, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that Dr. John Thoppil is the first physician in the state of Texas to offer its Sonata® Treatment to women with symptomatic uterine fibroids as an office-based procedure at his River Place ...
By Gynesonics
-
Gynesonics Announces FDA Clearance of Next Generation Sonata System
Redwood City, CA, September 16, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today the Food and Drug Administration (FDA) has given clearance of the Sonata® System 2.2 which provides important new benefits for facilities, physicians and patients. These benefits include: ...
By Gynesonics
-
Gynesonics Announces Anthem, the Second Largest Healthcare Payer in the U.S., Issues Medical Necessity Coverage for the Treatment of Symptomatic Uterine Fibroids with the Sonata Procedure
Redwood City, CA, September 14, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced Anthem, Inc., the largest managed health care company in the Blue Cross Blue Shield Association, has provided positive payer coverage for the Sonata® Treatment. Anthem’s decision creates ...
By Gynesonics
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you